Pasquale Viggiano, Maria Oliva Grassi, Giulia Bisceglia, Giacomo Boscia, Enrico Borrelli, Maria Giovanna Malerba, Antonio Fracchiolla, Giovanni Alessio, Francesco Boscia
PURPOSE: To evaluate short-term peripapillary structural and vascular changes in DME after treatment with dexamethasone implant (DEX-I) and anti-VEGFs using OCT-A. METHODS: Sixty-five patients with naïve center-involving DME were enrolled. 33 of sixty five patients (group 1) underwent with single DEX-I 0.7 mg (Ozurdex, Allergan, Inc., USA), 32 of sixty-five (group 2) underwent with intravitreal injection of aflibercept 0.5 mg (Eylea, Bayer, Genentech, San Francisco, USA)...
March 20, 2023: European Journal of Ophthalmology